A Study of E6011 in Participants With Active Crohn's Disease

49, CCR Ostrava, s.r.o, Ostrava

15, University of Debrecen Clinical Centre, Debrecen

19, Semmelweis university, Győr

4, Nagoya

17, Toyota

10, Abiko

31, Kashiwa

27, Kitakyushu

39, Kitakyushu

29, Kasamatsuchō

41, Kure

38, Asahikawa

26, Sapporo

37, Kobe

7, Nishinomiya

32, Kanazawa

8, Takamatsu

52, Isehara

30, Ōiso

28, Urasoe

42, Hirakata

51, Hamamatsu

50, Shuntougun

2, Bunkyo

33, Hachiōji

34, Kodaira

3, Minato

6, Mitaka

43, Shinagawa-Ku

1, Shinjuku

36, Akita

25, Fukuoka

35, Fukuoka

11, Gifu

5, Kagoshima

40, Kanazawa

24, Osaka

21, Vitamed Galaj i Cichomski sp.j., Bydgoszcz

22, Vita Longa, Katowice

20, Clinical Research Center sp. z o.o., Medic-R Sp. k., Poznan

23, Centrum Badań Klinicznych - Ośrodek Badań Wczesnej Fazy, Wroclaw

45, Federal Siberian Research and Clinical Center, Krasnoyarsk

44, LLC, Novosibirskiy Gastrocenter, Novosibirsk

46, Pyatigorsk City Clinical Hospital, Pyatigorsk

48, LLC Clinic, UZI 4D, Pyatigorsk

47, City Hospital of Saint Martyr Elizaveth, Saint Petersburg